Erica Erlank to 1-Phosphatidylinositol 4-Kinase
This is a "connection" page, showing publications Erica Erlank has written about 1-Phosphatidylinositol 4-Kinase.
Connection Strength
0,052
-
The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages. Sci Transl Med. 2022 10 19; 14(667):eabo7219.
Score: 0,052
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.